Delivery Order SPE2DE24D0013-SPE2D625F1E87

Award Date 3/4/25
Potential Completion Date 3/11/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency (DLA) for the supply of diagnostic testing equipment, reagents, and consumables for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $27,200.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid holds several significant federal contract Indefinite Delivery...
This federal contract award, valued at $2,310.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order for Cepheid to provide molecular diagnostic testing equipment, reagents, and test kits to support the detection and diagnosis of COVID-19 and other infectious diseases. This award is part of a larger Indefinite Delivery Vehicle (IDV) contract vehicle with the Department of...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has an award value of $5,440.00 and is a firm fixed-price delivery order. Cepheid will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, and test kits, to support the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This federal contract award, valued at $10,200.00, was issued to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract does not have a set-aside designation....
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $3,400.00, is for the provision of molecular diagnostic testing equipment, reagents, and consumables to detect COVID-19, influenza, respiratory syncytial virus (RSV), and other infectious diseases. The contract is a firm fixed-price arrangement with no set-aside designation. Cepheid holds several...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $2,244.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The products are intended to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F1E87
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $1,155.00, is a firm fixed-price delivery order for Cepheid to provide molecular diagnostic testing equipment, reagents, and consumables to support the detection and diagnosis of infectious diseases such as COVID-19, influenza, and other conditions.

The contract does not have a set-aside designation. Cepheid is the prime contractor and has provided these molecular diagnostic solutions to various federal agencies, including the Department of Veterans Affairs (VA) and Indian Health Service, through multiple Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements. These IDVs and agreements enable the continuous procurement of Cepheid's products and services, which are critical for healthcare providers to quickly detect and diagnose a range of medical conditions.

Generated 6/3/25, 10:07 AM